Company Filing History:
Years Active: 2002
Title: The Innovations of Brad Jameson
Introduction
Brad Jameson is an accomplished inventor based in Milton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target specific interactions in the immune system. His work is characterized by a focus on innovative solutions to complex medical challenges.
Latest Patents
Jameson holds a patent for "Pharmaceutical compositions thereof, and methods of using same." This invention relates to peptidomimetics capable of inhibiting the interaction between CD28 and/or CTLA-4 with CD80 (B7-1) and CD86 (B7-2). The core amino acid sequence of his invention is LeuMetTyrProProProTyrTyr, which corresponds to residues 2 to 9 of SEQ ID NO:1. The patent also encompasses pharmaceutical compositions and methods for treating various pathologies and disorders that can be improved by inhibiting these interactions.
Career Highlights
Jameson is associated with Applied Research Systems Ars Holding N.V., where he continues to push the boundaries of pharmaceutical research. His innovative approach has led to advancements that could potentially improve treatment options for patients suffering from immune-related disorders.
Collaborations
Throughout his career, Jameson has collaborated with notable professionals in the field, including Nabil El Tayar and Steven Blechner. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Brad Jameson's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patent and collaborative efforts reflect a dedication to improving healthcare outcomes through innovative research.